The Disruptive Comparison

Old World vs. Bio-Fab

We are not improving a process; our technology eliminates the hurdles that stalled regenerative medicine for decades: Cost / convoluted use / clinical outcomes

Competitors

The legacy industry relies on a staggering 11-stage industrial and clinical cycle:
1. Source Material Acquisition from human donors or animals.
2. Screening and Qualification of biological matter.
3. Processing and Preparation (enzymatic treatments, cell expansion in incubators).
4. Formulation and Assembly.
5. Sterilization or Aseptic Processing.
6. Quality Control and Release Testing.
7. Storage and sub-zero Distribution logistics.
8. Physician's sizing and measuring of the patient's unique wound.
9. Complicated ordering of pre-cut, generic patches.
10. Multiple physician's visits : Synchronizing and scheduling the patient's application appointment based on product delivery.
11. Costs of thousands of dollars per treatment.

The Bio-Fab Solution

By manufacturing biological products from off-the-shelf synthetics and readily available biologicals using a handheld printer, Bio-Interventions completely bypasses the billion-dollar manufacturing infrastructure and fragile logistics of the "Old World," while simultaneously eliminating the clinical nightmare of sizing, complicated ordering, and scheduling multiple physician visits to apply the products. Most importantly, this point-of-care revolution crushes the financial barrier—reducing legacy treatments that cost hundreds of dollars in the making and thousands of dollars to the end user down to single-digit manufacturing costs, making biological treatments, for the first time, as affordable and simple as a Nespresso cup of coffee.